A new study has shown up to a third of neovascular age-related macular degeneration (nAMD) patients may safely be able to stop intravitreal injections after a year, while also highlighting a potential biomarker to identify the best candidates. Read more
Specsavers has announced it will invest AU$110 million to cover the full clinic and optical store start-up costs for new partners as the company pursues its first foray into the North American market. Read more
Optometry NSW/ACT has advised that all staff working in optometry practices in NSW – including support staff – must have received at least one dose by the end of this month, or face being locked out of their employment, while Victoria has gone a step further and issued a booster shot mandate. Read more
The Optometry Board of Australia (OBA) has appointed New South Wales optometrist Mrs Judith Hannan as its new chair and has welcomed new optometrist board members for Tasmania and South Australia. Read more
Almost 18 months since its parent company announced Bausch + Lomb (B+L) would be spun off as a pure-play eye health company, the entity has filed for an initial public offering (IPO) on the New York and Toronto stock exchanges. Read more
For a third time, COVID-19 risks have prompted RANZCO to change its plans for the upcoming scientific congress, with the February conference now to be held as a virtual-only event. Read more
ASX-listed Healthia has entered into a binding agreement to acquire the eight-practice business LensPro Optometrists, securing its largest optometry acquisition since its 2020 takeover of The Optical Company. Read more
The Specsavers Graduate Recruitment Team have several exciting graduate opportunities available across Australia & New Zealand. With continued growth in providing eyecare to patients across ANZ, now is an exciting time to join a company that is leading and defining the future of the optical profession.
Smart contact lens startup Mojo Vision has signed strategic partnerships with leading sports and fitness brands. The company says it has identified an opportunity in the wearables market to deliver real-time performance data to athletes through its hands-free, eye-controlled user interface. Read more
Novartis has announced it is acquiring Gyroscope Therapeutics, the UK-based company behind an investigational dry ADM gene therapy that is the focus of key clinical trials in Australia. Read more